Retinal vessel tortuosity in response to hypobaric hypoxia

High Alt Med Biol. 2012 Dec;13(4):263-8. doi: 10.1089/ham.2011.1097.

Abstract

Purpose: Retinal vascular tortuosity is associated with retinopathy of differing etiologies, including hypertension, diabetes, and hypoxia. However, detailed understanding of the underlying pathophysiology is lacking. The aim of this study was to map changes in tortuosity associated with hypoxia at high altitude, and to determine the influence of sildenafil and an antioxidant preparation on altitude-induced tortuosity.

Methods: We measured the tortuosity of retinal vessels using a semi-automated method in 35 young, healthy subjects exposed to hypobaric hypoxia for 7 days at 5200 m, and compared the measurements to those from the same vessels at sea level. These subjects simultaneously took part in a randomized double-blind placebo-controlled trial of sildenafil and antioxidant. Comparison of tortuosity between these subgroups was performed.

Results: High altitude was associated with the development of retinal tortuosity in individual vessels. A nonsignificant trend suggests this is limited by prophylaxis with sildenafil or antioxidant.

Conclusions: Retinal vessel tortuosity increases rapidly at high altitude. We suggest that retinal vessel tortuosity at altitude may result from increased sheer stress causing elongation of vessel segments and that this might be limited by agents that act to preserve nitric oxide dependent vasodilation.

Trial registration numbers: NCT00664001, NCT00627965.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Altitude*
  • Antioxidants / therapeutic use*
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Humans
  • Hypoxia / complications*
  • Male
  • Mountaineering
  • Photography
  • Piperazines / therapeutic use*
  • Purines / therapeutic use
  • Retinal Diseases / etiology*
  • Retinal Diseases / pathology
  • Retinal Diseases / prevention & control
  • Retinal Vessels / pathology*
  • Sildenafil Citrate
  • Sulfones / therapeutic use*
  • Vasodilator Agents / therapeutic use*
  • Young Adult

Substances

  • Antioxidants
  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate

Associated data

  • ClinicalTrials.gov/NCT00627965
  • ClinicalTrials.gov/NCT00664001